• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunome, Inc. - Common Stock (NQ:IMNM)

9.120 +0.100 (+1.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 563,907
Open 8.980
Bid (Size) 9.000 (1)
Ask (Size) 9.670 (10)
Prev. Close 9.020
Today's Range 8.760 - 9.340
52wk Range 5.150 - 16.81
Shares Outstanding 87,012,328
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Today 16:05 EDT
From Immunome, Inc.
Via Business Wire
Immunome to Present at Upcoming Investor Conferences
May 22, 2025
From Immunome, Inc.
Via Business Wire

Performance

YTD
-13.4%
-13.4%
1 Month
+6.3%
+6.3%
3 Month
-2.5%
-2.5%
6 Month
-18.2%
-18.2%
1 Year
-37.6%
-37.6%

More News

Read More
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From Immunome, Inc.
Via Business Wire
Analyst Expectations For Immunome's Future
November 08, 2024
Via Benzinga
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2025
From Immunome, Inc.
Via Business Wire
Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference
April 04, 2025
From Immunome, Inc.
Via Business Wire
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2025
From Immunome, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 26, 2025
Via Benzinga
Immunome Reports Full Year 2024 Financial Results and Provides Business Update
March 19, 2025
From Immunome, Inc.
Via Business Wire
Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC
March 10, 2025
From Immunome, Inc.
Via Business Wire
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2025
From Immunome, Inc.
Via Business Wire
Immunome to Present at Upcoming March Conferences
February 25, 2025
From Immunome, Inc.
Via Business Wire
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2025
From Immunome, Inc.
Via Business Wire
Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 31, 2025
From Immunome, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 30, 2025
Via Benzinga
Immunome Announces Pricing of Upsized Public Offering of Common Stock
January 29, 2025
From Immunome, Inc.
Via Business Wire
Curious about the stocks that are showing activity after the closing bell on Wednesday?
January 29, 2025
Via Chartmill
Immunome Announces Proposed Public Offering of Common Stock
January 29, 2025
From Immunome, Inc.
Via Business Wire
Immunome Provides Pipeline Update in Advance of Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
From Immunome, Inc.
Via Business Wire
Hummingbird Bioscience Licenses Novel Antibodies to Immunome
January 07, 2025
From Hummingbird Bioscience
Via GlobeNewswire
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 02, 2025
From Immunome, Inc.
Via Business Wire
3 Small-Cap Stocks With Big Growth Potential
December 13, 2024
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2024
From Immunome, Inc.
Via Business Wire
Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
From Immunome, Inc.
Via Business Wire
Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update
November 13, 2024
From Immunome, Inc.
Via Business Wire

Frequently Asked Questions

Is Immunome, Inc. - Common Stock publicly traded?
Yes, Immunome, Inc. - Common Stock is publicly traded.
What exchange does Immunome, Inc. - Common Stock trade on?
Immunome, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunome, Inc. - Common Stock?
The ticker symbol for Immunome, Inc. - Common Stock is IMNM on the Nasdaq Stock Market
What is the current price of Immunome, Inc. - Common Stock?
The current price of Immunome, Inc. - Common Stock is 9.120
When was Immunome, Inc. - Common Stock last traded?
The last trade of Immunome, Inc. - Common Stock was at 06/05/25 04:00 PM ET
What is the market capitalization of Immunome, Inc. - Common Stock?
The market capitalization of Immunome, Inc. - Common Stock is 793.55M
How many shares of Immunome, Inc. - Common Stock are outstanding?
Immunome, Inc. - Common Stock has 794M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap